University of Navarre
Scleroderma medication receives orphan medication designation in Europe
Published in Lab Law Weekly, November 11th, 2005
This approval, achieved by the Digna Biotech biotechnological company, will facilitate the clinical development of its p144 peptide in the treatment of local and systemic scleroderma.
The aim of Digna Biotech is the development CIMA intellectual property at the University of Navarre on pre-clinical, clinical and commercial levels.
This p144 designation mean a series of advantages for the clinical development that Digna...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
Source: Lab Law Weekly (2005-11-11)
More Articles from Lab Law Weekly
- Acon Laboratories, Inc.
CLIA waiver received for drugs of abuse tests - Acuity Medical
Macular degeneration device improves vision in 26% of treated eyes in trial - Aerie Pharmaceuticals, Inc.
Glaucoma therapy developer closes $21M series A financing - Amnis Corp.
Three issued patents cover firm's expansions - Bausch & Lomb
Medicare reimbursement terms for Retisert published - Connetics Corp.
Dermatology-focused company files patent infringement lawsuit against Agis - More from this issue of Lab Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
